Literature DB >> 23526307

A geometric framework for evaluating rare variant tests of association.

Keli Liu1, Shannon Fast, Matthew Zawistowski, Nathan L Tintle.   

Abstract

The wave of next-generation sequencing data has arrived. However, many questions still remain about how to best analyze sequence data, particularly the contribution of rare genetic variants to human disease. Numerous statistical methods have been proposed to aggregate association signals across multiple rare variant sites in an effort to increase statistical power; however, the precise relation between the tests is often not well understood. We present a geometric representation for rare variant data in which rare allele counts in case and control samples are treated as vectors in Euclidean space. The geometric framework facilitates a rigorous classification of existing rare variant tests into two broad categories: tests for a difference in the lengths of the case and control vectors, and joint tests for a difference in either the lengths or angles of the two vectors. We demonstrate that genetic architecture of a trait, including the number and frequency of risk alleles, directly relates to the behavior of the length and joint tests. Hence, the geometric framework allows prediction of which tests will perform best under different disease models. Furthermore, the structure of the geometric framework immediately suggests additional classes and types of rare variant tests. We consider two general classes of tests which show robustness to noncausal and protective variants. The geometric framework introduces a novel and unique method to assess current rare variant methodology and provides guidelines for both applied and theoretical researchers.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23526307      PMCID: PMC3718063          DOI: 10.1002/gepi.21722

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  38 in total

1.  Approaches for evaluating rare polymorphisms in genetic association studies.

Authors:  Qizhai Li; Hong Zhang; Kai Yu
Journal:  Hum Hered       Date:  2010-03-24       Impact factor: 0.444

2.  Extending rare-variant testing strategies: analysis of noncoding sequence and imputed genotypes.

Authors:  Matthew Zawistowski; Shyam Gopalakrishnan; Jun Ding; Yun Li; Sara Grimm; Sebastian Zöllner
Journal:  Am J Hum Genet       Date:  2010-11-12       Impact factor: 11.025

3.  Incorporating model uncertainty in detecting rare variants: the Bayesian risk index.

Authors:  Melanie A Quintana; Jonine L Berstein; Duncan C Thomas; David V Conti
Journal:  Genet Epidemiol       Date:  2011-08-26       Impact factor: 2.135

4.  A data-driven method for identifying rare variants with heterogeneous trait effects.

Authors:  Qunyuan Zhang; Marguerite R Irvin; Donna K Arnett; Michael A Province; Ingrid Borecki
Journal:  Genet Epidemiol       Date:  2011-08-04       Impact factor: 2.135

5.  Detecting rare and common variants for complex traits: sibpair and odds ratio weighted sum statistics (SPWSS, ORWSS).

Authors:  Tao Feng; Robert C Elston; Xiaofeng Zhu
Journal:  Genet Epidemiol       Date:  2011-05-18       Impact factor: 2.135

6.  A new testing strategy to identify rare variants with either risk or protective effect on disease.

Authors:  Iuliana Ionita-Laza; Joseph D Buxbaum; Nan M Laird; Christoph Lange
Journal:  PLoS Genet       Date:  2011-02-03       Impact factor: 5.917

7.  Weighted selective collapsing strategy for detecting rare and common variants in genetic association study.

Authors:  Yilin Dai; Renfang Jiang; Jianping Dong
Journal:  BMC Genet       Date:  2012-02-06       Impact factor: 2.797

8.  The empirical power of rare variant association methods: results from sanger sequencing in 1,998 individuals.

Authors:  Martin Ladouceur; Zari Dastani; Yurii S Aulchenko; Celia M T Greenwood; J Brent Richards
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

9.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

Authors:  Manuel A Rivas; Mélissa Beaudoin; Agnes Gardet; Christine Stevens; Yashoda Sharma; Clarence K Zhang; Gabrielle Boucher; Stephan Ripke; David Ellinghaus; Noel Burtt; Tim Fennell; Andrew Kirby; Anna Latiano; Philippe Goyette; Todd Green; Jonas Halfvarson; Talin Haritunians; Joshua M Korn; Finny Kuruvilla; Caroline Lagacé; Benjamin Neale; Ken Sin Lo; Phil Schumm; Leif Törkvist; Marla C Dubinsky; Steven R Brant; Mark S Silverberg; Richard H Duerr; David Altshuler; Stacey Gabriel; Guillaume Lettre; Andre Franke; Mauro D'Amato; Dermot P B McGovern; Judy H Cho; John D Rioux; Ramnik J Xavier; Mark J Daly
Journal:  Nat Genet       Date:  2011-10-09       Impact factor: 38.330

10.  An evaluation of statistical approaches to rare variant analysis in genetic association studies.

Authors:  Andrew P Morris; Eleftheria Zeggini
Journal:  Genet Epidemiol       Date:  2010-02       Impact factor: 2.135

View more
  18 in total

1.  A general approach for combining diverse rare variant association tests provides improved robustness across a wider range of genetic architectures.

Authors:  Brian Greco; Allison Hainline; Jaron Arbet; Kelsey Grinde; Alejandra Benitez; Nathan Tintle
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

2.  Analysis of rare variant population structure in Europeans explains differential stratification of gene-based tests.

Authors:  Matthew Zawistowski; Mark Reppell; Daniel Wegmann; Pamela L St Jean; Margaret G Ehm; Matthew R Nelson; John Novembre; Sebastian Zöllner
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

3.  IMPROVED PERFORMANCE OF GENE SET ANALYSIS ON GENOME-WIDE TRANSCRIPTOMICS DATA WHEN USING GENE ACTIVITY STATE ESTIMATES.

Authors:  Thomas Kamp; Micah Adams; Craig Disselkoen; Nathan Tintle
Journal:  Pac Symp Biocomput       Date:  2017

4.  Testing genetic association with rare and common variants in family data.

Authors:  Han Chen; Dörthe Malzahn; Brunilda Balliu; Cong Li; Julia N Bailey
Journal:  Genet Epidemiol       Date:  2014-09       Impact factor: 2.135

5.  Pathway analysis approaches for rare and common variants: insights from Genetic Analysis Workshop 18.

Authors:  Stella Aslibekyan; Marcio Almeida; Nathan Tintle
Journal:  Genet Epidemiol       Date:  2014-09       Impact factor: 2.135

6.  A generalized genetic random field method for the genetic association analysis of sequencing data.

Authors:  Ming Li; Zihuai He; Min Zhang; Xiaowei Zhan; Changshuai Wei; Robert C Elston; Qing Lu
Journal:  Genet Epidemiol       Date:  2014-01-30       Impact factor: 2.135

7.  Modest impact on risk for autism spectrum disorder of rare copy number variants at 15q11.2, specifically breakpoints 1 to 2.

Authors:  Pauline Chaste; Stephan J Sanders; Kommu N Mohan; Lambertus Klei; Youeun Song; Michael T Murtha; Vanessa Hus; Jennifer K Lowe; A Jeremy Willsey; Daniel Moreno-De-Luca; Timothy W Yu; Eric Fombonne; Daniel Geschwind; Dorothy E Grice; David H Ledbetter; Catherine Lord; Shrikant M Mane; Donna M Martin; Eric M Morrow; Christopher A Walsh; James S Sutcliffe; Matthew W State; Christa Lese Martin; Bernie Devlin; Arthur L Beaudet; Edwin H Cook; Soo-Jeong Kim
Journal:  Autism Res       Date:  2014-05-12       Impact factor: 5.216

8.  Extension of SKAT to multi-category phenotypes through a geometrical interpretation.

Authors:  Emmanuelle Génin; Hervé Perdry; Ozvan Bocher; Gaelle Marenne; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2021-01-14       Impact factor: 5.351

9.  Evaluation of the power and type I error of recently proposed family-based tests of association for rare variants.

Authors:  Allison Hainline; Carolina Alvarez; Alexander Luedtke; Brian Greco; Andrew Beck; Nathan L Tintle
Journal:  BMC Proc       Date:  2014-06-17

10.  Evaluating the impact of genotype errors on rare variant tests of association.

Authors:  Kaitlyn Cook; Alejandra Benitez; Casey Fu; Nathan Tintle
Journal:  Front Genet       Date:  2014-04-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.